Ibuprofen and Kava
Supplement–drug interaction evidence from the TruthStack database.
| Severity | MODERATE |
|---|---|
| Evidence Tier | Moderate |
| Interaction Type | SAFETY CONCERN |
| Last Reviewed | 2026-02-24 |
Summary
Both kava and NSAIDs carry hepatotoxicity risk. Combined use increases hepatic burden.
Higher-Concern Contexts
This interaction may be of particular concern in the following contexts:
- hepatic impairment
CYP Enzyme Profiles
Published CYP enzyme data for compounds in this interaction:
Ibuprofen: CYP2C9 substrate (strong)
Kava: CYP1A2 inhibitor (moderate), CYP2D6 inhibitor (moderate), CYP2E1 inhibitor (strong), CYP3A4 inhibitor (weak)
API Reference
GET https://api.truthstack.co/v1/check?c1=Ibuprofen&c2=Kava
Open, unauthenticated. Returns JSON. Developer documentation
Related Interactions
What this page is and is not. TruthStack is an informational reference database that describes published pharmacological findings. It does not provide medical advice, diagnosis, or treatment recommendations. The information on this page reflects flags in our database and should not replace consultation with a qualified healthcare provider. Always discuss supplement-drug combinations with your prescriber or pharmacist.